Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 4/20 | 0.48 |
| ▸ | KIF11 | P52732 | 2/20 | 0.43 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.38 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29749591 | 1.00 | ACHE (0.48) | ACHEKIF11PTPN5CYP3A4CYP2D6 | |
| SCHEMBL30144876 | 0.84 | ACHE (0.46) | ACHEKIF11PTPN5CYP3A4CYP2D6 | |
| SCHEMBL25875486 | 0.84 | ACHE (0.46) | ACHEKIF11PTPN5CYP3A4CYP2D6 | |
| SCHEMBL19360441 | 0.84 | ACHE (0.46) | ACHEKIF11PTPN5CYP3A4CYP2D6 | |
| SCHEMBL822037 | 0.82 | ACHE (0.48) | ACHEKIF11PTPN5CYP3A4CYP2D6 | |
| SCHEMBL5360594 | 0.82 | ACHE (0.48) | ACHEKIF11PTPN5CYP3A4CYP2D6 | |
| SCHEMBL148048 | 0.81 | NFE2L2 (0.55) | ACHEKIF11PTPN5MAPK1ALDH1A1 | |
| SCHEMBL822098 | 0.81 | ACHE (0.52) | ACHEKIF11PTPN5CYP3A4CYP2D6 | |
| SCHEMBL25093467 | 0.81 | PTPN5 (0.44) | ACHEKIF11PTPN5CYP3A4CYP2D6 | |
| SCHEMBL19642633 | 0.81 | PTPN5 (0.44) | ACHEKIF11PTPN5CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4696748-A1 | PERFLUOROPOLYETHER GEL CURABLE COMPOSITION, PERFLUOROPOLYETHER GEL CURED PRODUCT, AND ELECTRONIC COMPONENT SEALED WITH SAID CURED PRODUCT | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-02-18 | — | — | EP | disclosed |
| US-12545761-B2 | Photocurable fluoropolyether-based elastomer composition and bonding method thereof | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-02-10 | — | — | US | disclosed |
| WO-2024214452-A1 | PERFLUOROPOLYETHER GEL CURABLE COMPOSITION, PERFLUOROPOLYETHER GEL CURED PRODUCT, AND ELECTRONIC COMPONENT SEALED WITH SAID CURED PRODUCT | 信越化学工業株式会社 | 2024-10-17 | — | — | WO | disclosed |
| US-20220396662-A1 | PHOTOCURABLE FLUOROPOLYETHER-BASED ELASTOMER COMPOSITION AND BONDING METHOD THEREOF | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2022-12-15 | — | — | US | disclosed |
| EP-4059994-A1 | PHOTOCURABLE FLUOROPOLYETHER ELASTOMER COMPOSITION AND BONDING METHOD FOR SAME | Shin-Etsu Chemical Co., Ltd. (JP) | 2022-09-21 | — | — | EP | disclosed |
| US-20220002580-A1 | METHOD FOR FORMING COATING FILM OF PHOTOCURABLE FLUOROPOLYETHER-BASED ELASTOMER COMPOSITION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2022-01-06 | — | — | US | disclosed |
| EP-3892391-A1 | METHOD FOR FORMING COATING FILM OF PHOTOSETTING FLUOROPOLYETHER-BASED ELASTOMER COMPOSITION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-10-13 | — | — | EP | disclosed |
| WO-2020116125-A1 | METHOD FOR FORMING COATING FILM OF PHOTOSETTING FLUOROPOLYETHER-BASED ELASTOMER COMPOSITION | 信越化学工業株式会社 | 2020-06-11 | — | — | WO | disclosed |
| EP-3053945-B1 | PHOTO-CURABLE FLUOROPOLYETHER-BASED RUBBER COMPOSITION, CURING METHOD THEREOF AND CURED PRODUCT OBTAINED BY THE CURING METHOD | SHINETSU CHEMICAL CO (JP) | 2017-12-27 | — | — | EP | disclosed |
| US-9840601-B2 | Method for producing a cured product | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-12-12 | — | — | US | disclosed |
| US-6458803-B1 | COMPOSITIONS AND METHODS FOR TREATING ATHEROSCLEROSIS AND OTHER CORONARY ARTERY DISEASES. PREFERRED TERTIARY-HETEROALKYLAMINE COMPOUNDS ARE SUBSTITUTED N-PHENYL-N-HETEROARALKYL AMINOALCOHOLS. A PREFERRED SPECIFIC | G.D. SEARLE & CO. | 2002-10-01 | — | — | US | disclosed |
| US-6455519-B1 | TREATING ATHEROSCLEROSIS AND CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. | 2002-09-24 | — | — | US | disclosed |
| US-6451830-B1 | Use of substituted N,N-disubstituted non-fused heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity | G.D. SEARLE & CO. | 2002-09-17 | — | — | US | disclosed |
| US-6451823-B1 | Use of substituted N-phenoxy-N-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity | G.D. SEARLE & CO. | 2002-09-17 | — | — | US | disclosed |
| US-6448295-B1 | TREATING CARDIOVASCULAR DISEASE; ATHEROSCLEROSIS, DYSLIPIDEMA HYPERCHOLESTEROLAEMIA; DECREASING CONCENTRATIONS OF LOW DENSITY LIPOPROTEIN AND RAISING LEVEL OF HIGH DENSITY LIPOPROTEIN | G.D. SEARLE & CO. | 2002-09-10 | — | — | US | disclosed |
| US-20020120011-A1 | Substituted N, N-disubstituted diamino compounds useful for inhibiting cholesteryl ester transfer protein activity | SIKORSKI JAMES A (US) | 2002-08-29 | — | — | US | disclosed |
| EP-1115695-A1 | (R)-CHIRAL HALOGENATED 1-SUBSTITUTEDAMINO-(N+1)-ALKANOLS USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY | Monsanto Company (US) | 2001-07-18 | — | — | EP | disclosed |
| EP-1115693-A1 | SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY | Monsanto Company (US) | 2001-07-18 | — | — | EP | disclosed |
| WO-2000018724-A1 | (R)-CHIRAL HALOGENATED 1-SUBSTITUTEDAMINO-(n+1)-ALKANOLS USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY | MONSANTO COMPANY (US) | 2000-04-06 | — | — | WO | disclosed |
| WO-2000018721-A1 | SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL TERTIARY-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY | MONSANTO COMPANY (US) | 2000-04-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12545761-B2 | Photocurable fluoropolyether-based elastomer composition and bonding method thereof | RAD51, FRG1, COL2A1 | ACHE 4765/4885KIF11 1845/4885PTPN5 4575/4885 |
| US-20020120011-A1 | Substituted N, N-disubstituted diamino compounds useful for inhibiting cholesteryl ester transfer protein activity | CETP, PCTP, DBI | ACHE 4445/4885KIF11 4638/4885PTPN5 3739/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.